atorvastatin has been researched along with Osteogenic Sarcoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fromigué, O; Girault, I; Habel, N; Hamidouche, Z; Lecanda, F; Marie, PJ; Patiño-García, A | 1 |
| Huang, Y; Li, X; Zhang, C; Zhao, S | 1 |
| Fromigué, O; Hamidouche, Z; Marie, PJ | 2 |
| Barbry, P; Fromigue, O; Hamidouche, Z; Lecanda, F; Mari, B; Marie, PJ; Patino, A; Vaudin, P | 1 |
| Auberger, P; Bouvet, S; Fromigué, O; Haÿ, E; Jacquel, A; Marie, PJ; Modrowski, D | 1 |
| Balcells, S; Blanch, J; Carreras, R; Díez-Perez, A; Enjuanes, A; Grinberg, D; Mellibovsky, L; Monllau, JC; Nogues, X; Pedro-Botet, J; Ruiz-Gaspa, S | 1 |
7 other study(ies) available for atorvastatin and Osteogenic Sarcoma
| Article | Year |
|---|---|
Zinc chelation: a metallothionein 2A's mechanism of action involved in osteosarcoma cell death and chemotherapy resistance.
Topics: Adolescent; Atorvastatin; Cell Death; Cell Differentiation; Cell Line, Tumor; Cell Survival; Chelating Agents; Child; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Gene Silencing; Heptanoic Acids; Humans; Metallothionein; Osteoblasts; Osteosarcoma; Prognosis; Protein Conformation; Pyrroles; RNA, Messenger; Tumor Suppressor Protein p53; Zinc | 2013 |
Downregulation of connective tissue growth factor reduces migration and invasiveness of osteosarcoma cells.
Topics: Apoptosis; Atorvastatin; Cell Line, Tumor; Cell Movement; Cell Survival; Connective Tissue Growth Factor; Down-Regulation; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Neoplasm Invasiveness; Osteosarcoma | 2016 |
Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion.
Topics: Animals; Apoptosis; Atorvastatin; Cell Line, Tumor; Cell Movement; Heptanoic Acids; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; MAP Kinase Kinase 4; MAP Kinase Signaling System; Matrix Metalloproteinase 14; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasm Invasiveness; Osteosarcoma; Phosphorylation; Proto-Oncogene Proteins c-jun; Pyrroles; rho GTP-Binding Proteins; rhoA GTP-Binding Protein; Tissue Inhibitor of Metalloproteinase-2 | 2008 |
CYR61 downregulation reduces osteosarcoma cell invasion, migration, and metastasis.
Topics: Animals; Apoptosis; Atorvastatin; Bone and Bones; Cell Line; Cell Movement; Cell Proliferation; Cell Survival; Cysteine-Rich Protein 61; Down-Regulation; Gene Expression Regulation, Neoplastic; Heptanoic Acids; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Osteosarcoma; Prenylation; Pyrroles | 2011 |
RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation.
Topics: Anticholesteremic Agents; Apoptosis; Atorvastatin; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Caspases; Cell Differentiation; Cell Survival; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Heptanoic Acids; Humans; Osteosarcoma; Phenotype; Phosphorylation; Polyisoprenyl Phosphates; Protein Transport; Proto-Oncogene Proteins c-bcl-2; Pyridines; Pyrroles; rhoA GTP-Binding Protein; RNA, Messenger; Signal Transduction; Simvastatin; Transforming Growth Factor beta | 2006 |
Simvastatin and atorvastatin enhance gene expression of collagen type 1 and osteocalcin in primary human osteoblasts and MG-63 cultures.
Topics: Aged; Atorvastatin; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Collagen Type I; Gene Expression Regulation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Osteoblasts; Osteocalcin; Osteosarcoma; Pyrroles; Simvastatin; Transforming Growth Factor beta | 2007 |
Statin-induced inhibition of 3-hydroxy-3-methyl glutaryl coenzyme a reductase sensitizes human osteosarcoma cells to anticancer drugs.
Topics: Antineoplastic Agents; Apoptosis; Atorvastatin; Cell Line, Tumor; Cell Movement; Cell Survival; Cisplatin; Doxorubicin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Matrix Metalloproteinase 2; Osteosarcoma; Pyrroles | 2008 |